Abstract
Several papers about lymphangiogenesis and inflammation focused on the detailed and complicated descriptions of the molecular pathways accompanying both non-tumor and tumor inflammatory-induced lymphatic vessel development. Many authors are tempted to present inflammatory-induced lymphangiogenesis in pathologic conditions neglecting the role of inflammatory cells during embryonic lymphatic vessel development. Some of the inflammatory cells are largely characterized in inflammatory-induced lymphangiogenesis, while others as mast cells, eosinophils, or plasma cells are less studied. No phenotypic characterization of inflammation-activated lymphatic endothelial cell is available in this moment. Another paradox is related to the existence of few papers regarding lymphangiogenesis inside lymphoid organs and for their related pathology. There are still several “missing pieces of such a big puzzle” of lymphangiogenesis and inflammation, with a direct impact on the ineffectiveness of the anti-inflammatory therapy as lymphangiogenesis inhibitors. The present paper will focus on the controversial issues of lymphangiogenesis and inflammation.
Similar content being viewed by others
References
Abtahian F, Guerriero A, Sebzda E et al (2003) Regulation of blood and lymphatic vascular separation by signaling proteins SLP-76 and Syk. Science 299:247–251
Aebischer D, Willrodt AH, Halin C (2014) Oxazolone-induced contact hypersensitivity reduces lymphatic drainage but enhances the induction of adaptive immunity. PLoS ONE 9:e99297
Akishima Y, Ito K, Zhang L et al (2004) Immunohistochemical detection of human small lymphatic vessels under normal and pathological conditions using the LYVE-1 antibody. Virchows Arch 444:153–157
Algaba A, Linares PM, Fernández-Contreras ME et al (2013) Relationship between levels of angiogenic and lymphangiogenic factors and the endoscopic, histological and clinical activity, and acute-phase reactants in patients with inflammatory bowel disease. J Crohns Colitis 7:e569–e579
Al-Rawi MA, Mansel RE, Jiang WG (2005) Molecular and cellular mechanisms of lymphangiogenesis. Eur J Surg Oncol 31:117–121
Angeli V, Ginhoux F, Llodrà J et al (2006) B cell-driven lymphangiogenesis in inflamed lymph nodes enhances dendritic cell mobilization. Immunity 24:203–215
Bao H, Jiang M, Zhu M et al (2009) Overexpression of Annexin II affects the proliferation, apoptosis, invasion and production of proangiogenic factors in multiple myeloma. Int J Hematol 90:177–185
Bekiaris V, Gaspal F, Kim MY et al (2009) CD30 is required for CCL21 expression and CD4 T cell recruitment in the absence of lymphotoxin signals. J Immunol 182:4771–4775
Bernaudin JF, Kambouchner M, Lacave R (2013) Lymphatic vascular system, development and lymph formation (in French). Rev Pneumol Clin 69:93–101
Berrih-Aknin S, Ruhlmann N, Bismuth J et al (2009) CCL21 overexpressed on lymphatic vessels drives thymic hyperplasia in myasthenia. Ann Neurol 66:521–531
Berro AI, Perry GA, Agrawal DK (2004) Increased expression and activation of CD30 induce apoptosis in human blood eosinophils. J Immunol 173:2174–2183
Best CL, Pudney J, Welch WR et al (1996) Localization and characterization of white blood cell populations within the human ovary throughout the menstrual cycle and menopause. Hum Reprod 11:790–797
Bischoff SC, Sellge G, Manns MP et al (2001) Interleukin-4 induces a switch of human intestinal mast cells from proinflammatory cells to Th2-type cells. Int Arch Allergy Immunol 124:151–154
Bogos K, Renyi-Vamos F, Dobos J et al (2009) High VEGFR-3-positive circulating lymphatic/vascular endothelial progenitor cell level is associated with poor prognosis in human small cell lung cancer. Clin Cancer Res 15:1741–1746
Böhmer R, Neuhaus B, Bühren S et al (2010) Regulation of developmental lymphangiogenesis by Syk(+) leukocytes. Dev Cell 18:437–449
Bouta EM, Wood RW, Brown EB et al (2014) In vivo quantification of lymph viscosity and pressure in lymphatic vessels and draining lymph nodes of arthritic joints in mice. J Physiol 592(Pt 6):1213–1223
Brideau G, Mäkinen MJ, Elamaa H et al (2007) Endostatin overexpression inhibits lymphangiogenesis and lymph node metastasis in mice. Cancer Res 67:11528–11535
Brown HM, Russell DL (2014) Blood and lymphatic vasculature in the ovary: development, function and disease. Hum Reprod Update 20:29–39
Cao Y, Linden P, Farnebo J et al (1998) Vascular endothelial growth factor C induces angiogenesis in vivo. Proc Natl Acad Sci USA 95:14389–14394
Cimpean AM, Mazuru V, Cernii A et al (2011) Detection of early lymphangiogenesis by lymphatic microvascular density and endothelial proliferation status in preneoplastic and neoplastic lesions of the uterine cervix. Pathol Int 61:395–400
Cimpean AM, Mazuru V, Saptefrati L et al (2012) Prox 1, VEGF-C and VEGFR3 expression during cervical neoplasia progression as evidence of an early lymphangiogenic switch. Histol Histopathol 27:1543–1550
Crivellato E, Nico B, Ribatti D (2008) Mast cells and tumour angiogenesis: new insight from experimental carcinogenesis. Cancer Lett 269:1–6
Cueni LN, Detmar M (2008) The lymphatic system in health and disease. Lymphat Res Biol 6:109–122
Dellinger MT, Meadows SM, Wynne K et al (2013) Vascular endothelial growth factor receptor-2 promotes the development of the lymphatic vasculature. PLoS ONE 8:e74686
Detoraki A, Staiano RI, Granata F et al (2009) Vascular endothelial growth factors synthesized by human lung mast cells exert angiogenic effects. J Allergy Clin Immunol 123:1142–1149
Detry B, Blacher S, Erpicum C et al (2013) Sunitinib inhibits inflammatory corneal lymphangiogenesis. Invest Ophthalmol Vis Sci 54:3082–3093
Duong T, Proulx ST, Luciani P et al (2012) Genetic ablation of SOX18 function suppresses tumor lymphangiogenesis and metastasis of melanoma in mice. Cancer Res 72:3105–3114
El Filali E, Duijst S, Hiralall JK et al (2014) Human fetal liver cells for regulated ex vivo erythropoietin gene therapy. Mol Ther Methods Clin Dev 1:1–5
Farnsworth RH, Achen MG, Stacker SA (2006) Lymphatic endothelium: an important interactive surface for malignant cells. Pulm Pharmacol Ther 19:51–60
Fiedler U, Christian S, Koidl S et al (2006) The sialomucin CD34 is a marker of lymphatic endothelial cells in human tumors. Am J Pathol 168:1045–1053
Flister MJ, Wilber A, Hall KL et al (2010) Inflammation induces lymphangiogenesis through upregulation of VEGFR-3 mediated by NF-kappaB and Prox1. Blood 115:418–429
Fridlender ZG, Albelda SM (2013) Modifying tumor associated macrophages: an important adjunct to immunotherapy. Oncoimmunology 2:e26620
Fukuhara J, Kase S, Ohashi T (2013) Expression of vascular endothelial growth factor C in human pterygium. Histochem Cell Biol 139:381–389
Furtado GC, Marinkovic T, Martin AP et al (2007) Lymphotoxin beta receptor signaling is required for inflammatory lymphangiogenesis in the thyroid. Proc Natl Acad Sci USA 104:5026–5031
Gabillot-Carré M, Lepelletier Y, Humbert M et al (2006) Rapamycin inhibits growth and survival of D816V-mutated c-kit mast cells. Blood 108:1065–1072
Galli SJ, Grimbaldeston M, Tsai M (2008) Immunomodulatory mast cells: negative, as well as positive, regulators of immunity. Nat Rev Immunol 8:478–486
Gan HK, Seruga B, Knox JJ (2009) Sunitinib in solid tumors. Expert Opin Investig Drugs 18:821–834
Genovese A, Detoraki A, Granata F et al (2012) Angiogenesis, lymphangiogenesis and atopic dermatitis. Chem Immunol Allergy 96:50–60
Golenkov AK, Buravtsova IV, Dudina GA et al (2013) Gene expression of vascular endothelial growth factors and their receptors in different variants of the course of multiple myeloma (in Russian). Ter Arkh 85:98–102
Gordon S, Taylor PR (2005) Monocyte and macrophage heterogeneity. Nat Rev Immunol 5:953–964
Gordon EJ, Rao S, Pollard JW et al (2010) Macrophages define dermal lymphatic vessel calibre during development by regulating lymphatic endothelial cell proliferation. Development 137:3899–3910
Gordon K, Schulte D, Brice G et al (2013a) Mutation in vascular endothelial growth factor-C, a ligand for vascular endothelial growth factor receptor-3, is associated with autosomal dominant milroy-like primary lymphedema. Circ Res 112:956–960
Gordon K, Spiden SL, Connell FC et al (2013b) FLT4/VEGFR3 and Milroy disease: novel mutations, a review of published variants and database update. Hum Mutat 34:23–31
Grimbaldeston MA, Chen CC, Piliponsky AM et al (2005) Mast cell-deficient W-sash c-kit mutant Kit W-sh/W-sh mice as a model for investigating mast cell biology in vivo. Am J Pathol 167:835–848
Hall MA, Robinson H, Chan W et al (2013) Detection of lymphangiogenesis by near-infrared fluorescence imaging and responses to VEGF-C during healing in a mouse full-dermis thickness wound model. Wound Repair Regen 21:604–615
Hameed A, Fox WM, Kurman RJ et al (1995) Perforin expression in human cell-mediated luteolysis. Int J Gynecol Pathol 14:151–157
Harvey NL, Gordon EJ (2012) Deciphering the roles of macrophages in developmental and inflammation stimulated lymphangiogenesis. Vasc Cell 4:15
Hos D, Saban DR, Bock F et al (2011) Suppression of inflammatory corneal lymphangiogenesis by application of topical corticosteroids. Arch Ophthalmol 129:445–452
Huggenberger R, Ullmann S, Proulx ST et al (2010) Stimulation of lymphangiogenesis via VEGFR-3 inhibits chronic skin inflammation. J Exp Med 207:2255–2269
Huggenberger R, Siddiqui SS, Brander D et al (2011) An important role of lymphatic vessel activation in limiting acute inflammation. Blood 117:4667–4678
Ji RC (2012) Macrophages are important mediators of either tumor- or inflammation-induced lymphangiogenesis. Cell Mol Life Sci 69:897–914
Ji RC, Eshita Y (2014) Rapamycin inhibition of CFA-induced lymphangiogenesis in PLN is independent of mast cells. Mol Biol Rep 41:2217–2228
Johnson LA, Jackson DG (2013) Control of dendritic cell trafficking in lymphatics by chemokines. Angiogenesis 17:335–345
Kajiya K, Sawane M, Huggenberger R et al (2009) Activation of the VEGFR-3 pathway by VEGF-C attenuates UVB-induced edema formation and skin inflammation by promoting lymphangiogenesis. J Invest Dermatol 129:1292–1298
Kalitin NN, Kostyukova MN, Kakpakova ES et al (2012) Expression of vascular endothelial growth factor receptors VEGFR1 in cultured multiple myeloma cells: correlation with immunophenotype and drug resistance. Bull Exp Biol Med 153:882–885
Kanner WA, Galgano MT, Atkins KA (2010) Podoplanin expression in basal and myoepithelial cells: utility and potential pitfalls. Appl Immunohistochem Mol Morphol 18:226–230
Kataru RP, Kim H, Jang C et al (2011) T lymphocytes negatively regulate lymph node lymphatic vessel formation. Immunity 34:96–107
Kato S, Shimoda H, Ji RC et al (2006) Lymphangiogenesis and expression of specific molecules as lymphatic endothelial cell markers. Anat Sci Int 81:71–83
Kelley PM, Connor AL, Tempero RM (2013) Lymphatic vessel memory stimulated by recurrent inflammation. Am J Pathol 182:2418–2428
Kerjaschki D, Regele HM, Moosberger I et al (2004) Lymphatic neoangiogenesis in human kidney transplants is associated with immunologically active lymphocytic infiltrates. J Am Soc Nephrol 15:603–612
Kim H, Cruz M, Bourdeau A et al (2013) Cell-cell interactions influence vascular reprogramming by Prox1 during embryonic development. PLoS ONE 8:e52197
Klueh U, Antar O, Qiao Y et al (2014) Role of vascular networks in extending glucose sensor function: impact of angiogenesis and lymphangiogenesis on continuous glucose monitoring in vivo. J Biomed Mater Res A 102:3512–3522
Kume T (2010) Specification of arterial, venous, and lymphatic endothelial cells during embryonic development. Histol Histopathol 25:637–646
Kunder CA, St John AL, Li G et al (2009) Mast cell-derived particles deliver peripheral signals to remote lymph nodes. J Exp Med 206:2455–2467
Kunder CA, St John AL, Abraham SN (2011) Mast cell modulation of the vascular and lymphatic endothelium. Blood 118:5383–5393
Lachance PA, Hazen A, Sevick-Muraca EM (2013) Lymphatic vascular response to acute inflammation. PLoS ONE 8:e76078
Lahdenranta J, Hagendoorn J, Padera TP et al (2009) Endothelial nitric oxide synthase mediates lymphangiogenesis and lymphatic metastasis. Cancer Res 69:2801–2808
Leak LV, Cadet JL, Griffin CP et al (1995) Nitric oxide production by lymphatic endothelial cells in vitro. Biochem Biophys Res Commun 217:96–105
Lee JY, Park C, Cho YP et al (2010) Podoplanin-expressing cells derived from bone marrow play a crucial role in postnatal lymphatic neovascularization. Circulation 122:1413–1425
Lee BS, Lee BC, Park JE et al (2014) Primo vascular system in human umbilical cord and placenta. J Acupunct Meridian Stud 7:291–297
Ling S, Liang L, Lin H et al (2012) Increasing lymphatic microvessel density in primary pterygia. Arch Ophthalmol 130:735–742
Liu L, Ling SQ, Li QL et al (2012) Relations between lymphangiogenesis and the size of pterygium. Int J Ophthalmol 5:312–316
Loffredo S, Staiano RI, Granata F et al (2014) Immune cells as a source and target of angiogenic and lymphangiogenic factors. Chem Immunol Allergy 99:15–36
Long KB, Beatty GL (2013) Harnessing the antitumor potential of macrophages for cancer immunotherapy. Oncoimmunology 2:e26860
Mantovani A, Sica A, Sozzani S et al (2004) The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 25:677–686
Mareel M, Oliveira MJ, Madani I (2009) Cancer invasion and metastasis: interacting ecosystems. Virchows Arch 454:599–622
Maruyama K, Ii M, Cursiefen C et al (2005) Inflammation-induced lymphangiogenesis in the cornea arises from CD11b-positive macrophages. J Clin Invest 115:2363–2372
Masuzawa M, Masuzawa M, Hamada Y et al (2012) Establishment and characterization of a novel lymphangiosarcoma cell line (MO-LAS) compared with the hemangiosarcoma cell line (ISO-HAS). Cancer Med 1:39–46
Matsumoto M, Roufail S, Inder R et al (2013) Signaling for lymphangiogenesis via VEGFR-3 is required for the early events of metastasis. Clin Exp Metastasis 30:819–832
Miteva M, Galimberti ML, Ricotti C et al (2009) D2-40 highlights lymphatic vessel proliferation of angiolymphoid hyperplasia with eosinophilia. J Cutan Pathol 36:1316–1322
Mounzer RH, Svendsen OS, Baluk P et al (2010) Lymphotoxin-alpha contributes to lymphangiogenesis. Blood 116:2173–2182
Mouta Carreira C, Nasser SM, di Tomaso E et al (2001) LYVE-1 is not restricted to the lymph vessels: expression in normal liver blood sinusoid and down-regulation in human liver cancer and cirrhosis. Cancer Res 61:8079–8084
Nagy JA, Vasile E, Feng D et al (2002) Vascular permeability factor/vascular endothelial growth factor induces lymphangiogenesis as well as angiogenesis. J Exp Med 196:1497–1506
Neri S, Ishii G, Hashimoto H et al (2015) Podoplanin-expressing cancer-associated fibroblasts lead and enhance the local invasion of cancer cells in lung adenocarcinoma. Int J Cancer. doi:10.1002/ijc.29464
Nilsson I, Bahram F, Li X et al (2010) VEGF receptor 2/-3 heterodimers detected in situ by proximity ligation on angiogenic sprouts. EMBO J 29:1377–1388
Nitta A, Shirasuna K, Haneda S et al (2011) Possible involvement of IFNT in lymphangiogenesis in the corpus luteum during the maternal recognition period in the cow. Reproduction 142:879–892
Oka M, Iwata C, Suzuki HI et al (2008) Inhibition of endogenous TGF-beta signaling enhances lymphangiogenesis. Blood 111:4571–4579
Palomba A, Gallo O, Brahimi A et al (2010) Evaluation of lymphangiogenesis in premalignant conditions of the head and neck mucosa. Head Neck 32:1681–1685
Patel SP, Dana R (2009) Corneal lymphangiogenesis: implications in immunity. Semin Ophthalmol 24:135–138
Pearse G (2006) Normal structure, function and histology of the thymus. Toxicol Pathol 34:504–514
Peranzoni E, Zilio S, Marigo I et al (2010) Myeloid-derived suppressor cell heterogeneity and subset definition. Curr Opin Immunol 22:238–244
Proulx ST, Luciani P, Dieterich LC et al (2013) Expansion of the lymphatic vasculature in cancer and inflammation: new opportunities for in vivo imaging and drug delivery. J Control Release 172:550–557
Qiu H, Cao L, Wang D et al (2013) High levels of circulating CD34+/VEGFR3+ lymphatic/vascular endothelial progenitor cells is correlated with lymph node metastasis in patients with epithelial ovarian cancer. J Obstet Gynaecol Res 39:1268–1275
Quek R, George S (2010) Update on the treatment of gastrointestinal stromal tumors (GISTs): role of imatinib. Biologics 4:19–31
Raica M, Cimpean AM, Ribatti D (2008) The role of podoplanin in tumor progression and metastasis. Anticancer Res 28:2997–3006
Raica M, Kondylis A, Mogoantă L et al (2010) Diagnostic and clinical significance of D2-40 expression in the normal human thymus and thymoma. Rom J Morphol Embryol 51:229–234
Raica M, Cimpean AM, Ceausu R et al (2013) Interplay between mast cells and lymphatic vessels in different molecular types of breast cancer. Anticancer Res 33:957–963
Ramani P, Norton A, Somerville MS et al (2012) PROX1 lymphatic density correlates with adverse clinicopathological factors, lymph node metastases and survival in neuroblastomas. J Neurooncol 108:375–383
Russo E, Nitschké M, Halin C (2013) Dendritic cell interactions with lymphatic endothelium. Lymphat Res Biol 11:172–182
Salmi M, Karikoski M, Elima K et al (2013) CD44 binds to macrophage mannose receptor on lymphatic endothelium and supports lymphocyte migration via afferent lymphatics. Circ Res 112:1577–1582
Salven P, Mustjoki S, Alitalo R et al (2003) VEGFR-3 and CD133 identify a population of CD34+ lymphatic/vascular endothelial precursor cells. Blood 101:168–172
Schlereth SL, Neuser B, Caramoy A et al (2014) Enrichment of lymphatic vessel endothelial hyaluronan receptor 1 (LYVE-1)-positive macrophages around blood vessels in the normal human sclera. Invest Ophthalmol Vis Sci 55:865–872
Schmid MC, Varner JA (2012) Myeloid cells in tumor inflammation. Vasc Cell 4:14
Schoppmann SF, Jesch B, Zacherl J et al (2013) Lymphangiogenesis and lymphovascular invasion diminishes prognosis in esophageal cancer. Surgery 153:526–534
Schuijs MJ, Willart MA, Hammad H et al (2013) Cytokine targets in airway inflammation. Curr Opin Pharmacol 13:351–361
Schwarz EM, Proulx ST, Ritchlin CT et al (2010) The role of bone marrow edema and lymphangiogenesis in inflammatory-erosive arthritis. Adv Exp Med Biol 658:1–10
Secker GA, Harvey NL (2015) VEGFR signaling during lymphatic vascular development: from progenitor cells to functional vessels. Dev Dyn 244:323–331
Shapira I, Sultan KS, Taioli E et al (2011) Role of myeloid derived hematopoietic cells in inflammation and immune tolerance to cancer. OncoReviews 1:1–12
Shimamura K, Nakatani T, Ueda A et al (2009) Relationship between lymphangiogenesis and exudates during the wound-healing process of mouse skin full-thickness wound. Wound Repair Regen 17:598–605
Shimoda H, Kato S (2006) A model for lymphatic regeneration in tissue repair of the intestinal muscle coat. Int Rev Cytol 250:73–108
Shirasuna K, Nitta A, Sineenard J et al (2012) Vascular and immune regulation of corpus luteum development, maintenance, and regression in the cow. Domest Anim Endocrinol 43:198–211
Shoyinka SV, Emehelu CO, Ezeibe MC (2005) Malignant mastocytoma in a Nigerian local dog. Nigerian Vet J 26:45–50
Shukla S, Shukla H, Kumar S et al (2013) Allergy and inflammation: an immunological and therapeutic approach. Recent Pat Inflamm Allergy Drug Discov 7:135–150
Soucek L, Lawlor ER, Soto D et al (2007) Mast cells are required for angiogenesis and macroscopic expansion of Myc-induced pancreatic islet tumors. Nat Med 13:1211–1218
Takaya R, Fukaya T, Sasano H et al (1997) Macrophages in normal cycling human ovaries: immunohistochemical localization and characterization. Hum Reprod 127:1508–1512
Tammela T, Zarkada G, Wallgard E et al (2008) Blocking VEGFR-3 suppresses angiogenic sprouting and vascular network formation. Nature 454:656–660
Tammela T, Zarkada G, Nurmi H et al (2011) VEGFR-3 controls tip to stalk conversion at vessel fusion sites by reinforcing Notch signalling. Nat Cell Biol 13:1202–1213
Tan KW, Chong SZ, Wong FH et al (2013) Neutrophils contribute to inflammatory lymphangiogenesis by increasing VEGF-A bioavailability and secreting VEGF-D. Blood 122:3666–3677
Tan YZ, Wang HJ, Zhang MH et al (2014) CD34+VEGFR-3+ progenitor cells have a potential to differentiate towards lymphatic endothelial cells. J Cell Mol Med 18:422–433
Teijeira Á, Palazón A, Garasa S et al (2012) CD137 on inflamed lymphatic endothelial cells enhances CCL21-guided migration of dendritic cells. FASEB J 26:3380–3392
Theoharides TC, Alysandratos KD, Angelidou A et al (2012) Mast cells and inflammation. Biochim Biophys Acta 1822:21–33
Vacca A, Ria R, Ribatti D et al (2003) A paracrine loop in the vascular endothelial growth factor pathway triggers tumor angiogenesis and growth in multiple myeloma. Haematologica 88:176–185
Van’t Hull EF, Bron S, Henry L et al (2014) Bone marrow-derived cells are implicated as a source of lymphatic endothelial progenitors in human breast cancer. Oncoimmunology 3:e29080
Vigl B, Aebischer D, Nitschké M et al (2011) Tissue inflammation modulates gene expression of lymphatic endothelial cells and dendritic cell migration in a stimulus-dependent manner. Blood 118:205–215
Xu F, Stouffer RL (2009) Existence of the lymphatic system in the primate corpus luteum. Lymphat Res Biol 7:159–168
Yiannakopoulou E (2012) Modulation of lymphangiogenesis: a new target for aspirin and other nonsteroidal anti-inflammatory agents? A systematic review. J Clin Pharmacol 52:1749–1754
Yin N, Zhang N, Xu J et al (2011) Targeting lymphangiogenesis after islet transplantation prolongs islet allograft survival. Transplantation 92:25–30
Zarkada G, Heinolainen K, Makinen T et al (2015) VEGFR3 does not sustain retinal angiogenesis without VEGFR2. Proc Natl Acad Sci USA 112:761–766
Zhang L, Giraudo E, Hoffman JA et al (2006) Lymphatic zip codes in premalignant lesions and tumors. Cancer Res 66:5696–5706
Zhang Q, Lu Y, Proulx ST et al (2007) Increased lymphangiogenesis in joints of mice with inflammatory arthritis. Arthritis Res Ther 9:R118
Zimmer JK, Dahdal S, Mühlfeld C et al (2010) Lymphangiogenesis is upregulated in kidneys of patients with multiple myeloma. Anat Rec 293:1497–1505
Zumsteg A, Christofori G (2012) Myeloid cells and lymphangiogenesis. Cold Spring Harb Perspect Med 2:a006494
Zumsteg A, Baeriswyl V, Imaizumi N et al (2009) Myeloid cells contribute to tumor lymphangiogenesis. PLoS ONE 4:e7067
Acknowledgments
This work was supported by UEFSCDI grant IDEAS 345/2011 and “Victor Babes” University of Medicine and Pharmacy Timisoara, Romania—internal research grant—Innovative Basic Research Program PIII-C1-CFI-2014/2015-02.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
None declared.
About this article
Cite this article
Cimpean, A.M., Raica, M. Lymphangiogenesis and Inflammation—Looking for the “Missing Pieces” of the Puzzle. Arch. Immunol. Ther. Exp. 63, 415–426 (2015). https://doi.org/10.1007/s00005-015-0349-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00005-015-0349-7